Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
inhaler
Pharma
FTC blasts Teva for 'improper' inhaler patents
After filing a challenge against more than 100 patents in the FDA’s Orange Book, the Federal Trade Commission has singled out Teva in an amicus brief.
Fraiser Kansteiner
Mar 25, 2024 10:04am
GSK sets $35 out-of-pocket price cap for its inhalers in the US
Mar 21, 2024 11:45am
AstraZeneca enlists Walter the Dino to paint rivals as outdated
Mar 21, 2024 7:12am
Boehringer cuts out-of-pocket inhaler prices to $35 in US
Mar 7, 2024 11:10am
Chiesi works with BBC to spread message about greener inhalers
Dec 5, 2023 8:55am
Kindeva captures £33M UK grant to boost inhaler production
Aug 8, 2023 8:30am